(Q36604393)

15 August 2017

1 reference

title

ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? (English)

1 reference

15 August 2017

1

P Vince Jenkins

1 reference

15 August 2017

James S O'Donnell

2

1 reference

15 August 2017

1 October 2006

1 reference

15 August 2017

1 reference

15 August 2017

46

1 reference

15 August 2017

10

1 reference

15 August 2017

1836-1844

1 reference

Blood groups and disease: a historical perspective

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

The blood group-specific human glycosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Blood group antigens: molecules seeking a function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Biochemistry and genetics of von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Carbohydrate-Specific Receptors of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Increased clearance of von Willebrand factor antigen post-DDAVP in Type 1 von Willebrand disease: is it a potential pathogenic process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Primary structure of the major O-glycosidically linked carbohydrate unit of human von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Measurement of von Willebrand factor activity: relative effects of ABO blood type and race

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Intraplatelet von willebrand factor and ABO blood group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Amino acid sequence of human von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Increased susceptibility of von Willebrand factor to proteolysis by ADAMTS13: should the multimer profile be normal or type 2A?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

Differential effect of the ABO blood group on von Willebrand factor collagen binding activity and ristocetin cofactor assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2006.00975.X

10.1111/J.1537-2995.2006.00975.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17002642